Altre lingue Xenetic Biosciences, Inc.

Azioni

XBIO

US9840156023

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:01 03/05/2024			Variaz. 5gg	Var. 1 gen.
4,27 ^USD	+9,49%		+4,40%	+23,76%

21/03	Xenetic Biosciences, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
18/03	CLS Therapeutics rivela le sue opinioni su Xenetic Biosciences	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results	25/03
Xenetic Biosciences : Reports Full Year 2023 Financial Results - Form 8-K	22/03
Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
CLS Therapeutics Discloses its Views on Xenetic Biosciences	18/03
Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of Its DNase-Based Oncology Platform	17/01
Xenetic Biosciences: Q3 Earnings Snapshot	10/11
Xenetic Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference	12/10/23
Xenetic Biosciences: Q2 Earnings Snapshot	11/08/23
Xenetic Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
North American Morning Briefing : Debt-Ceiling -2-	17/05/23
Xenetic Biosciences to Implement 1-for-10 Reverse Split	12/05/23
Xenetic Biosciences: Q1 Earnings Snapshot	11/05/23
XENETIC BIOSCIENCES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	11/05/23
Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
Xenetic Biosciences, The Scripps Research Institute Enter Into Research Collaboration	11/04/23
Xenetic Biosciences : Reports Full Year 2022 Financial Results and Provides Business Update - Form 8-K	23/03/23
XENETIC BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22/03/23
XENETIC BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22/12/22
XENETIC BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	09/12/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Xenetic Biosciences, Inc.

Azioni

XBIO

US9840156023

Altre lingue

Filtri